$SUIC
SUIC Worldwide Holdings Ltd. Stock $suic

$suic Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000155479524000105 Filed on April 15, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$30.00K	$150.0K	$45.00K
YoY Change	-33.33%	-32.13%	-74.29%
Cost Of Revenue	$40.00K	$40.00K	$82.14K
YoY Change	-51.3%	-51.3%	-14.44%
Gross Profit	-$10.00K	$110.0K	-$37.14K
YoY Change	-73.07%	-20.78%	-147.01%
Gross Profit Margin	-33.33%	73.33%	-82.53%
Selling, General & Admin	$31.38K	$80.92K	-$77.87K
YoY Change	-140.3%	25.73%	-202.98%
% of Gross Profit		73.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.00	$50.00	$10.00
YoY Change	0.0%	0.0%	0.0%
% of Gross Profit		0.05%
Operating Expenses	$31.38K	$89.92K	-$77.87K
YoY Change	-140.3%	39.69%	-202.98%
Operating Profit	-$41.38K	$20.08K	$40.73K
YoY Change	-201.6%	-73.04%	1105.03%
Interest Expense	-$4.980K	-$15.25K	-$6.220K
YoY Change	-19.94%	-27.38%	26.42%
% of Operating Profit		-75.95%	-15.27%
Other Income/Expense, Net	$1.130K	$20.09K	-$73.98K
YoY Change	-101.53%	-135.93%	-6589.47%
Pretax Income	-$45.22K	$7.825K	-$39.47K
YoY Change	14.57%	-423.35%	9526.83%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$45.22K	$7.825K	-$39.47K
YoY Change	14.57%	-423.35%	9526.83%
Net Earnings / Revenue	-150.73%	5.22%	-87.71%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	11.36M shares	4.125M shares	33.50M shares
Diluted Shares Outstanding		283.1M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.60K	$37.60K	$46.07K
YoY Change	-18.39%	-18.39%	-23.02%
Cash & Equivalents	$7.600K		$16.07K
Short-Term Investments	$30.00K	$30.00K	$30.00K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$186.8K	$186.8K	$362.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$224.4K	$224.4K	$408.6K
YoY Change	-45.08%	-45.08%	2.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$100.00	$100.00	$150.00
YoY Change	-33.33%	-33.33%	-25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$30.00K		$30.00K
YoY Change	0.0%		0.0%
Other Assets			$0.00
YoY Change
Total Long-Term Assets	$159.9K	$159.9K	$164.4K
YoY Change	-2.77%	-2.77%	-15.05%
TOTAL ASSETS
Total Short-Term Assets	$224.4K	$224.4K	$408.6K
Total Long-Term Assets	$159.9K	$159.9K	$164.4K
Total Assets	$384.3K	$384.3K	$573.0K
YoY Change	-32.94%	-32.94%	-3.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.00K	$35.47K	$1.760K
YoY Change	1604.55%	1915.34%	-21.08%
Accrued Expenses	$4.830K	$4.830K	$170.1K
YoY Change	-97.16%	-97.16%	-8.85%
Deferred Revenue
YoY Change
Short-Term Debt	$107.7K	$107.7K	$459.7K
YoY Change	-76.57%	-76.57%	166.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$148.0K	$148.0K	$631.6K
YoY Change	-76.56%	-76.56%	-2.62%
LONG-TERM LIABILITIES
Long-Term Debt	$279.0K	$279.0K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$279.0K	$279.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$148.0K	$148.0K	$631.6K
Total Long-Term Liabilities	$279.0K	$279.0K	$0.00
Total Liabilities	$427.0K	$427.0K	$631.6K
YoY Change	-32.39%	-32.39%	-2.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.732M		-$1.740M
YoY Change	-0.45%		0.14%
Common Stock	$41.50K		$33.50K
YoY Change	23.88%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$42.76K	-$42.76K	-$58.59K
YoY Change
Total Liabilities & Shareholders Equity	$384.3K	$384.3K	$573.0K
YoY Change	-32.94%	-32.94%	-3.27%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$45.22K	$7.825K	-$39.47K
YoY Change	14.57%	-423.35%	9526.83%
Depreciation, Depletion And Amortization	$10.00	$50.00	$10.00
YoY Change	0.0%	0.0%	0.0%
Cash From Operating Activities	$62.47K	$56.53K	$1.420K
YoY Change	4299.3%	-510.22%	-101.33%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-65.00K	-$65.00K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	62.47K	$56.53K	1.420K
Cash From Investing Activities	0.000		0.000
Cash From Financing Activities	-65.00K	-$65.00K	0.000
Net Change In Cash	-2.530K	-$8.472K	1.420K
YoY Change	-278.17%	-38.52%	-105.86%
FREE CASH FLOW
Cash From Operating Activities	$62.47K	$56.53K	$1.420K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	$62.47K	$56.53K	$1.420K
YoY Change	4299.3%	-510.22%	-101.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	SUIC	Bad Debt Expense BadDebtExpense		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001394108
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet		usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet		usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments		usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments		usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022	SUIC	Credit Loss Of Dividend Receivable CreditLossOfDividendReceivable		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022	SUIC	Credit Loss Of Dividend Receivable CreditLossOfDividendReceivable		usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables		usd
CY2023	SUIC	Other Income1 OtherIncome1		usd
CY2022	SUIC	Other Income2 OtherIncome2		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations		usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations		usd
CY2022	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	SUIC	Cash Paid For Income Taxesdiscontinued Operation CashPaidForIncomeTaxesdiscontinuedOperation		usd
CY2022	SUIC	Cash Paid For Income Taxesdiscontinued Operation CashPaidForIncomeTaxesdiscontinuedOperation		usd
CY2023	SUIC	Debt Discount Incurred From Beneficial Conversion Feature DebtDiscountIncurredFromBeneficialConversionFeature		usd
CY2022	SUIC	Debt Discount Incurred From Beneficial Conversion Feature DebtDiscountIncurredFromBeneficialConversionFeature		usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1731996	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-42761	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate		usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-53737
CY2023	dei	Entity Registrant Name EntityRegistrantName	SUIC Worldwide Holdings Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2148252
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	136-20 38th Ave.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit 3G
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Flushing
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11354
CY2023	dei	City Area Code CityAreaCode	(929)
CY2023	dei	Local Phone Number LocalPhoneNumber	391-2550
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	10923755	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11356638	shares
CY2023	dei	Auditor Firm AuditorFirmId	3826
CY2023	dei	Auditor Name AuditorName	James Pai, CPA
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7600	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16072	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	186799	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	362525	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	224399	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	408597	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	100	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	150	usd
CY2022Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	9000	usd
CY2023Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	11702	usd
CY2022Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	7202	usd
CY2023Q4	SUIC	Accrued Fees And Other Revenue Receivable1 AccruedFeesAndOtherRevenueReceivable1	2000	usd
CY2022Q4	SUIC	Accrued Fees And Other Revenue Receivable1 AccruedFeesAndOtherRevenueReceivable1	2000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	146078	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	146078	usd
CY2023Q4	us-gaap	Assets Assets	384279	usd
CY2022Q4	us-gaap	Assets Assets	573028	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	5474	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1764	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	107734	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	172734	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	4832	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	170115	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	148040	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	344613	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	279000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	287000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	279000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	287000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	394500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	394500000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11356638	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11356638	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11356638	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11356638	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	41504	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	33504	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1647731	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1647731	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1731996	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1739820	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-42761	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-58585	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	384279	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	573028	usd
CY2023	us-gaap	Revenues Revenues	150000	usd
CY2022	us-gaap	Revenues Revenues	221000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	40000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	82143	usd
CY2023	us-gaap	Gross Profit GrossProfit	110000	usd
CY2022	us-gaap	Gross Profit GrossProfit	138857	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	80920	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	64364	usd
CY2022	SUIC	Bad Debt Expense BadDebtExpense	105000	usd
CY2023	SUIC	Credit Loss Of Dividend Receivable CreditLossOfDividendReceivable	9000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	89920	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	169364	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	20080	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-30507	usd
CY2023	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	4836	usd
CY2022	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	19091	usd
CY2023	SUIC	Other Income From Cancellation Of Liability OtherIncomeFromCancellationOfLiability	3000	usd
CY2022	SUIC	Other Income From Cancellation Of Liability OtherIncomeFromCancellationOfLiability	30000	usd
CY2023	us-gaap	Other Income OtherIncome	7836	usd
CY2022	us-gaap	Other Income OtherIncome	49091	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	143	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	81	usd
CY2023	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	19948	usd
CY2022	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	20922	usd
CY2023	us-gaap	Other Expenses OtherExpenses	20091	usd
CY2022	us-gaap	Other Expenses OtherExpenses	21002	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	7825	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2419	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7825	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2419	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7825	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2419	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.00
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4125300	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3350360	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	283125300	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	290350360	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-56167	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2419	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-58585	usd
CY2022Q4	SUIC	Stockholders Equity After Reverse Stock Split StockholdersEquityAfterReverseStockSplit	-58585	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	8000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7825	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-42761	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7825	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2419	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7825	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2419	usd
CY2023	us-gaap	Depreciation Depreciation	50	usd
CY2022	us-gaap	Depreciation Depreciation	50	usd
CY2023	SUIC	Credit Loss Of Dividend Receivable CreditLossOfDividendReceivable	9000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	175726	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23500	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	35574	usd
CY2022	SUIC	Other Income1 OtherIncome1	-2000	usd
CY2023	SUIC	Other Income2 OtherIncome2	9000	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-4500	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-4500	usd
CY2023	us-gaap	Depreciation Depreciation	50	usd
CY2022	us-gaap	Depreciation Depreciation	50	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	3710	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-464	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	30000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-165283	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-16519	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	56528	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13778	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56528	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13778	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	65000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-65000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8472	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13778	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16072	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29850	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7600	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16072	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	143	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	21002	usd
CY2023Q4	us-gaap	Capital Capital	76359	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zGFizFOoVURl" style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_86A_zqNlXvUiwkK8">Use of Estimates</span></span></p> <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results. Significant accounting estimates reflected in the Company’s consolidated financial statements included the valuation of accounts receivable, the estimated useful lives of long-term assets, the valuation of short-term investment and the valuation of deferred tax assets.</span></p>
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	105000	usd
CY2023Q4	SUIC	Shortterm Debt Fair Value Unpaid Balance ShorttermDebtFairValueUnpaidBalance	323	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	186799	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	362525	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	186799	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	362525	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	279000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	172734	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	279000	usd
CY2023Q4	SUIC	Accrued Interest Unpaid Balance AccruedInterestUnpaidBalance	4474	usd
CY2023	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	18355	usd
CY2023Q4	SUIC	Cancelled Accrued Interest Payable CancelledAccruedInterestPayable	83260	usd
CY2023Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	107734	usd
CY2023	SUIC	Debt Instrument Increase Accrued Interest1 DebtInstrumentIncreaseAccruedInterest1	1592	usd
CY2023	SUIC	Debt Instrument Increase Accrued Interest Unpaid Balance1 DebtInstrumentIncreaseAccruedInterestUnpaidBalance1	2972	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	949224	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	214062	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	215705	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	214062	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	215705	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7825	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2419	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1643	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-508	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1643	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-508	usd

Files In Submission

Name	View Source	Status
0001554795-24-000105-index-headers.html	Edgar Link	pending
0001554795-24-000105-index.html	Edgar Link	pending
0001554795-24-000105.txt	Edgar Link	pending
0001554795-24-000105-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
suic-20231231.xsd	Edgar Link	pending
suic0415form10k.htm	Edgar Link	pending
suic0415form10kexh31_1.htm	Edgar Link	pending
suic0415form10kexh31_2.htm	Edgar Link	pending
suic0415form10kexh32_1.htm	Edgar Link	pending
suic0415form10kexh32_2.htm	Edgar Link	pending
suic-20231231_def.xml	Edgar Link	unprocessable
suic-20231231_lab.xml	Edgar Link	unprocessable
suic-20231231_pre.xml	Edgar Link	unprocessable
suic0415form10k_htm.xml	Edgar Link	completed
suic-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SUIC
SUIC Worldwide Holdings Ltd. Stock $suic

2023 Q4 Form 10-K Financial Statement

#000155479524000105 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUIC SUIC Worldwide Holdings Ltd. Stock $suic

2023 Q4 Form 10-K Financial Statement

#000155479524000105 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUIC
SUIC Worldwide Holdings Ltd. Stock $suic